Wang, Di
He, Li
Li, Chunhui
Xu, Menglei
Yu, Qiuxia
Almeida, Varlene Daniela Fernandes
Que, Yimei
Xu, Yanjie
Xiao, Yi
Li, Chunrui
Funding for this research was provided by:
National Natural Science Foundation of China (81300410, 81873444, 82170223)
Article History
Received: 6 November 2022
Accepted: 10 February 2023
First Online: 22 February 2023
Declarations
:
: The two patients in this study were enrolled in clinical trials registered at ExternalRef removed with registry number ChiCTR1800018137 (for patient 1) and ChiCTR-OPN-16008526 (for patient 2), both conducted at the Department of Hematology of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in China. This study was approved by the Medical Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology. Both patients gave their written informed consents to participate in the CAR-T study. All methods were carried out in accordance with the Declaration of Helsinki.
: Written informed consent to publish was obtained from the participant to report individual patient data.
: The authors: no reported conflicts of interest. All authors have submitted the ICMJE form for disclosure of potential conflicts of interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.